Literature DB >> 3276579

Geriatric hypertension: the growing use of calcium-channel blockers.

J C Busse1, B J Materson.   

Abstract

The recognition of essential hypertension as a heterogeneous entity mandates that therapy be individualized according to the subset of hypertension that characterizes each patient. Choosing the most appropriate therapeutic regimen in elderly hypertensives is complicated by a greater susceptibility to side effects from medications, and by concomitant diseases. Calcium-channel blockers address the pathophysiologic mechanisms of generic hypertension, thus providing clinicians with more specific pharmacologic tools for treating elderly hypertensives. In addition, these agents will avoid many of the side effects of other antihypertensive agents and can ameliorate certain concomitant diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276579

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  3 in total

Review 1.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

2.  Hypertension in the elderly: what price therapy?

Authors:  M Gordon
Journal:  Can Fam Physician       Date:  1989-12       Impact factor: 3.275

Review 3.  Diltiazem. A review of its pharmacology and therapeutic use in older patients.

Authors:  A Markham; R N Brogden
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.